Appetite Loss and Anorexia of Aging in Clinical Care: An ICFSR Task Force Report.

Appetite Loss and Anorexia of Aging in Clinical Care: An ICFSR Task Force Report.
复制标题

DOI:
10.14283/jfa.2022.14
复制
发表时间:
2022
期刊:
The Journal of frailty & aging
影响因子:
--
通讯作者:
Fielding R
Fielding R
中科院分区:
其他
文献类型:
--
作者:
de Souto Barreto P;Cesari M;Morley JE;Roberts S;Landi F;Cederholm T;Rolland Y;Vellas B;Fielding R

文献摘要

被引文献

相似文献

衰老引起的食欲减退/厌食症是一种非常普遍且令人负担的老年综合症,严重损害老年人的生活质量。食欲不振与多种临床病症有关,包括合并症和其他老年综合征,例如虚弱。尽管食欲不振很重要,但它却被低估了,因此在常规临床护理中没有得到充分的诊断和治疗。国际衰弱和肌肉减少症研究会议 (ICFSR) 工作组于 2021 年 9 月 27 日举行虚拟会议,讨论与衰老引起的食欲不振/厌食症相关的问题。特别讨论了与高危老年人群食欲减退的实施和管理、衰老过程中的能量平衡以及该主题未来临床试验的设计相关的主题。该领域未来的行动应侧重于对老年人护理路径中食欲的系统评估,例如世界卫生组织推荐的老年人综合护理(ICOPE)计划。此外,临床护理应从评估食欲减退/厌食症转向治疗。研究人员继续努力寻找具有良好风险/效益比的有效药物和非药物干预措施。
Appetite loss/anorexia of aging is a highly prevalent and burdensome geriatric syndrome that strongly impairs the quality of life of older adults. Loss of appetite is associated with several clinical conditions, including comorbidities and other geriatric syndromes, such as frailty. Despite its importance, appetite loss has been under-evaluated and, consequently, under-diagnosed and under-treated in routine clinical care. The International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force met virtually on September 27th 2021 to debate issues related to appetite loss/anorexia of aging. In particular, topics related to the implementation and management of appetite loss in at-risk older adult populations, energy balance during aging, and the design of future clinical trials on this topic were discussed. Future actions in this field should focus on the systematic assessment of appetite in the care pathway of older people, such as the Integrated Care for Older People (ICOPE) program recommended by the World Health Organization. Moreover, clinical care should move from the assessment to the treatment of appetite loss/anorexia. Researchers continue to pursue their efforts to find out effective pharmacologic and non-pharmacologic interventions with a favorable risk/benefit ratio.